Galt Phranchise Systems

Galt Pharmaceuticals is a specialty pharmaceutical company that pioneered the "Phranchise" (pharmaceutical franchise) business model, the first of its kind in the industry. The company focuses on acquiring and commercializing established prescription drugs by leveraging a decentralized network of locally owned and operated sales territories. Their current commercial portfolio includes Doral (quazepam) for insomnia and Orphengesic Forte for musculoskeletal pain. By utilizing this unique model, Galt aims to improve patient access and clinical education for niche therapeutic products through high-touch, local representation.